当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3849552
自主品牌
已选条件
-
T9908PembrolizumabPembrolizumab
Pembrolizumab is a humanized monoclonal antibody inhibiting the PD-1 receptor and the first in the class of agents called the HER2 dimerization inhibitors that impairs the ability of HER2 to bind to other members of the HER family.
价 格：￥电议型 号：T9908产 地：中国大陆
-
T26520ABP688ABP688
ABP688 is a non-competitive and selective mGluR5 antagonist(Ki = 1.7 nM). ABP688 can be used as a PET tracer for clinical imaging.
价 格：￥电议型 号：T26520产 地：中国大陆
-
T7767FMoc-Val-Cit-PAB-PNPFMocValCitPABPNP,ADC Linkers,inhibit,Antibody-drug conjugates linkers,Inhibitor,
Fmoc-Val-Cit-PAB-PNP is a linker for Antibody-Drug-Conjugation (ADC).
价 格：￥电议型 号：T7767产 地：中国大陆
-
T9909PertuzumabPertuzumab
Pertuzumab anti-HER2) a humanized monoclonal antibody and the first in the class of agents called the HER2 dimerization inhibitors impairs the ability of HER2 to bind to other members of the HER family.
价 格：￥电议型 号：T9909产 地：中国大陆
-
T82898Bentracimab；化合物 BentracimabPB 2452|||MEDI 2452；PB 2452|||MEDI 2452
Bentracimab (PB 2452) is a monoclonal antibody that effectively neutralizes Ticagrelor and its primary active metabolite by binding with high affinity, facilitating the rapid reversal of Ticagrelor´s antiplatelet effects [1].
价 格：￥电议型 号：T82898产 地：中国大陆
-
T82696Cofetuzumab；化合物 CofetuzumabPF-06523435|||hu24；PF-06523435|||hu24
Cofetuzumab (PF-06523435) is a humanized IgG1-κ monoclonal antibody designed to target PTK7, with Chinese Hamster Ovary (CHO) cells acting as the primary expression system [1].
价 格：￥电议型 号：T82696产 地：中国大陆
-
T81854Marstacimab；化合物 MarstacimabPF-06741086；PF-06741086
Marstacimab (PF-06741086), an anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody, is utilized in hemophilia research [1] [2].
价 格：￥电议型 号：T81854产 地：中国大陆
-
T81401Pritoxaximab；化合物 PritoxaximabPritoxaximab
Pritoxaximab is an IgG1κ monoclonal antibody that selectively targets Shiga toxin type 1 [Stx1].
价 格：￥电议型 号：T81401产 地：中国大陆
-
T81400Pritumumab；化合物 PritumumabPritumumab
Pritumumab, a natural human IgG1kappa monoclonal antibody (mAb), was first isolated from the regional draining lymph node of a cervical carcinoma patient. It specifically recognizes cell-surface-expressed vimentin on malignant tumors and has applications in glioblastoma research [1] [2].
价 格：￥电议型 号：T81400产 地：中国大陆
-
T80616Posdinemab；化合物 PosdinemabPosdinemab
Posdinemab, a humanized IgG1κ antibody, targets the microtubule-associated protein tau (MAPT) [1].
价 格：￥电议型 号：T80616产 地：中国大陆
-
T80612Pimurutamab；化合物 PimurutamabPimurutamab
Pimurutamab, a humanized IgG1-κ antibody, selectively targets the epidermal growth factor receptor (EGFR) and is primarily produced by CHO-K1 cells [1].
价 格：￥电议型 号：T80612产 地：中国大陆
-
T80611Sasanlimab；化合物 SasanlimabPF-06801591；PF-06801591
Sasanlimab (PF-06801591), a humanized IgG4-κ antibody, selectively targets PD-1 and is primarily produced in Chinese Hamster Ovary (CHO) cells [1].
价 格：￥电议型 号：T80611产 地：中国大陆
-
T78960FABP4-IN-2；化合物 FABP4-IN-2FABP4-IN-2
FABP4-IN-2 (Compd 10g), a selective and orally active FABP4 inhibitor, exhibits K i values of 0.51 μM for FABP4 and 33.01 μM for FABP3, demonstrating its specificity towards FABP4. It is utilized in research investigating inflammatory diseases [1].
价 格：￥电议型 号：T78960产 地：中国大陆
-
T78330Peresolimab；化合物 PeresolimabPeresolimab
Peresolimab, a humanized IgG1-κ antibody, targets PD-1 and may activate physiological immune inhibitory pathways, thereby restoring immune homeostasis [1] [2].
价 格：￥电议型 号：T78330产 地：中国大陆
-
T78318Gatipotuzumab；化合物 GatipotuzumabPankoMab；PankoMab
Gatipotuzumab (PankoMab), a humanized monoclonal antibody, targets the tumor-specific epitope TA-MUC1 of mucin-1 and exhibits potent tumor-specific antibody-dependent cell cytotoxicity (ADCC) [1] [2].
价 格：￥电议型 号：T78318产 地：中国大陆
-
T7767FMoc-Val-Cit-PAB-PNP；化合物FMoc-Val-Cit-PAB-PNPFMocValCitPABPNP|||ADC Linkers|||inhibit|||Antibody-drug
Fmoc-Val-Cit-PAB-PNP is a linker for Antibody-Drug-Conjugation (ADC).
价 格：￥电议型 号：T7767产 地：中国大陆
-
T77178Pucotenlimab；化合物 PucotenlimabPucotenlimab
Pucotenlimab (HX008), a humanized immunoglobulin G4 (IgG4) monoclonal antibody targeting programmed cell death protein 1 (anti-PD-1), serves as a potential agent in tumor research [1].
价 格：￥电议型 号：T77178产 地：中国大陆
-
T77164Pimivalimab；化合物 PimivalimabPimivalimab
Pimivalimab (JTX-4014), a PD-1 inhibitor, is utilized in solid tumor research [1].
价 格：￥电议型 号：T77164产 地：中国大陆
-
T77163Pexelizumab；化合物 PexelizumabPexelizumab
Pexelizumab (h5G1.1-SC), a humanized scFv monoclonal antibody, targets the C5 complement component, thereby inhibiting apoptosis and leukocyte infiltration. It is utilized in researching cerebral ischemia-reperfusion (IR) injury and myocardial infarction [1] [2].
价 格：￥电议型 号：T77163产 地：中国大陆
-
T77139Pavurutamab；化合物 PavurutamabPavurutamab
Pavurutamab (AMG-701) is a bispecific T-cell engager that targets CD3 and B-cell maturation antigens (BCMA), based on the extended half-life derived from Pacanalotamab. Its Fc region is engineered for improved pharmacokinetics, offering potential in immune regulation and the treatment of multiple myeloma (MM) [1] [2] [3] [4].
价 格：￥电议型 号：T77139产 地：中国大陆
